
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitor... Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.05 | 1.44927536232 | 3.45 | 4.0999 | 3.264 | 42341 | 3.70216068 | CS |
4 | 0.29 | 9.03426791277 | 3.21 | 4.0999 | 3.0684 | 22221 | 3.54518516 | CS |
12 | 0.85 | 32.0754716981 | 2.65 | 4.0999 | 2.59 | 46060 | 3.03112438 | CS |
26 | -1.26 | -26.4705882353 | 4.76 | 7.3 | 2.01 | 148107 | 5.47366316 | CS |
52 | -11.25 | -76.2711864407 | 14.75 | 15.5 | 2.01 | 129102 | 8.32967382 | CS |
156 | -43 | -92.4731182796 | 46.5 | 92.5 | 2.01 | 191124 | 22.16934578 | CS |
260 | -390.75 | -99.1122384274 | 394.25 | 449.75 | 2.01 | 215562 | 70.47254921 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions